List of redirects
Jump to navigation
Jump to search
Showing below up to 50 results in range #201 to #250.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)
- Hepatobiliary cancer → Hepatocellular carcinoma
- Hexamethylmelamine → Altretamine (Hexalen)
- Hexamethylmelamine (Altretamine) → Altretamine (Hexalen)
- Histiocytoses → Erdheim-Chester disease
- Hodgkin lymphoma → Classical Hodgkin lymphoma
- Hodgkin lymphoma, pediatric → Classical Hodgkin lymphoma, pediatric
- Hodgkin lymphoma, pediatric - historical → Classical Hodgkin lymphoma, pediatric - historical
- Hodgkin lymphoma - historical → Classical Hodgkin lymphoma - historical
- Hodgkin lymphoma - null regimens → Classical Hodgkin lymphoma - null regimens
- Homoharringtonine → Omacetaxine (Synribo)
- Hu5F9-G4 → Magrolimab (Hu5F9-G4)
- Hypereosinophilic syndrome (HES) → Hypereosinophilic syndrome
- ICD-9 → ICD-10 & ICD-9 codes
- ICD-9 codes → ICD-10 & ICD-9 codes
- IL-2 → Aldesleukin (Proleukin)
- IL2 → Aldesleukin (Proleukin)
- IMT → Inflammatory myofibroblastic tumor
- IPH 2101 (Anti-KIR) → IPH 2101
- IPI-145 → Duvelisib (IPI-145)
- ITP → Immune thrombocytopenia
- Ibritumomab (Zevalin) → Ibritumomab tiuxetan (Zevalin)
- Ibrutinib (PCI-32765) → Ibrutinib (Imbruvica)
- Idarucizumab → Idarucizumab (Praxbind)
- Idelalisib (CAL-101) → Idelalisib (Zydelig)
- Imetelstat → Imetelstat (GRN163L)
- Imetelstat (GRN-163L) → Imetelstat (Rytelo)
- Immune thrombocytopenia (ITP) → Immune thrombocytopenia
- Infigratinib (BGJ398) → Infigratinib (Truseltiq)
- Inflammitant → Vesicant & irritant chemotherapy
- Inotuzumab ozogamicin (CMC-544) → Inotuzumab ozogamicin (Besponsa)
- Iptacopan (LNP-023) → Iptacopan (Fabhalta)
- Irinotecan nanoliposomal (PEP02, MM-398) → Irinotecan liposome (Onivyde)
- Irritant → Vesicant & irritant chemotherapy
- Isatuximab (SAR-650984) → Isatuximab (Sarclisa)
- Ivosidenib (AG-120) → Ivosidenib (Tibsovo)
- Ixazomib (MLN9708) → Ixazomib (Ninlaro)
- JMML → Juvenile myelomonocytic leukemia
- Karnofsky performance status → Performance status
- Kidney cancer → Renal cell carcinoma
- Kyprolis → Carfilzomib (Kyprolis)
- LGL leukemia → Large granular lymphocytic leukemia
- Lambrolizumab (MK-3475) → Pembrolizumab (Keytruda)
- Large granular lymphocytic leukaemia → Large granular lymphocytic leukemia
- Larotrectinib (LOXO-101) → Larotrectinib (Vitrakvi)
- Leucovorin → Leucovorin (Folinic acid)
- Light chain amyloidosis → Light-chain (AL) amyloidosis
- Lipefilgrastim (XM22) → Lipefilgrastim (Lonquex)
- Lisocabtagene maraleucel (Liso-cel) → Lisocabtagene maraleucel (Breyanzi)
- List of chemotherapies → Drug index
- List of chemotherapy regimens → Main Page